Products Categories
CAS No.: | 89565-68-4 |
---|---|
Name: | Tropisetron |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C17H20N2O2 |
Molecular Weight: | 284.358 |
Synonyms: | 1H-Indole-3-carboxylicacid, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-;ICS 205-930;ICS205930;Navoban;1H-Indole-3-carboxylicacid, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; |
EINECS: | 1806241-263-5 |
Density: | 1.26 g/cm3 |
Melting Point: | 201-202 °C |
Boiling Point: | 448.5 °C at 760 mmHg |
Flash Point: | 225 °C |
Solubility: | Soluble in water |
Appearance: | white powder |
PSA: | 83.80000 |
LogP: | 4.38640 |
The Tropisetron is an organic compound with the formula C17H20N2O2. The IUPAC name of this chemical is [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate. With the CAS registry number 89565-68-4, it is also named as 1H-indole-3-carboxylic acid, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester. The product's classification codes are Antiemetics; Autonomic Agents; Central Nervous System Agents; Gastrointestinal Agents; Neurotransmitter Agents; Peripheral Nervous System Agents; Serotonin Agents; Serotonin antagonists.
The Tropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia. The drug is available in a 5 mg oral preparation or in 2 mg intravenous form. It is marketed by Novartis in Europe, Australia, New Zealand, Japan, South Korea and the Philippines as Navoban, but is not available in the U.S. It is also available from Novell Pharmaceutical Laboratories and marketed in several Asian countries as setrovel.
Physical properties about Tropisetron are: (1)ACD/LogP: 3.55; (2)ACD/LogD (pH 5.5): 0.47; (3)ACD/LogD (pH 7.4): 1.04; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1.68; (7)ACD/KOC (pH 7.4): 6.34; (8)#H bond acceptors: 4; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 3; (11)Polar Surface Area: 45.33 Å2; (12)Index of Refraction: 1.644; (13)Molar Refractivity: 81.49 cm3; (14)Molar Volume: 224.9 cm3; (15)Polarizability: 32.3×10-24cm3; (16)Surface Tension: 56.6 dyne/cm; (17)Density: 1.26 g/cm3; (18)Flash Point: 225 °C; (19)Enthalpy of Vaporization: 70.7 kJ/mol; (20)Boiling Point: 448.5 °C at 760 mmHg; (21)Vapour Pressure: 3.09E-08 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: CN4[C@@H]1CC[C@H]4C[C@H](C1)OC(=O)c3cnc2ccccc23
(2)InChI: InChI=1/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13+
(3)InChIKey: ZNRGQMMCGHDTEI-ITGUQSILBO
(4)Std. InChI: InChI=1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13+
(5)Std. InChIKey: ZNRGQMMCGHDTEI-ITGUQSILSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
women | TDLo | intravenous | 800ug/kg/2D-I (0.8mg/kg) | VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Lancet. Vol. 1, Pg. 1494, 1987. |